{
"@context": "https://schema.org",
"@type": "Article",
"headline": "S.D.N.Y. Partially Dismisses Claims Against Pharmaceutical Company, But Allows Claim Regarding Misleading Statements About Upcoming NDA for Rare Tissue Disorder To Proceed",
"url": "https://www.lexblog.com/2020/06/16/s-d-n-y-partially-dismisses-claims-against-pharmaceutical-company-but-allows-claim-regarding-misleading-statements-about-upcoming-nda-for-rare-tissue-disorder-to-proceed/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-RZ3285DV",
"url": "https://www.lexblog.com/lib/RZ3285DV/"
},
"datePublished": "2020-06-16T14:48:59-04:00",
"dateModified": "2021-11-01T07:41:24-04:00",
"author": {
"@type": "Person",
"name": "Gregg Weiner, Adam Harris, Chloe Gordils"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Ropes & Gray"
},
"organizationScope": "at-publication",
"isPartOf": "Life Sciences Securities Litigation",
"about": "Banking, Finance and Securities",
"sourceUrl": "http://lifescienceslitigation.ropesgrayblogs.com/?p=2042",
"sourceStability": "may-move"
}